top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
An Act to Amend the Federal Food, Drug, and Cosmetic Act Regarding the List Under Section 505(J)(X7) of the Federal Food, Drug, and Cosmetic Act, and for Other Purposes
An Act to Amend the Federal Food, Drug, and Cosmetic Act Regarding the List Under Section 505(J)(X7) of the Federal Food, Drug, and Cosmetic Act, and for Other Purposes
Pubbl/distr/stampa [Washington, D.C.] : , : [U.S. Government Publishing Office], , [2021]
Descrizione fisica 1 online resource (5 unnumbered pages)
Soggetto topico Patent laws and legislation - United States
Drugs - United States - Patents
Public health laws - United States
Soggetto genere / forma Statutes and codes.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Act to Amend the Federal Food, Drug, and Cosmetic Act Regarding the List Under Section 505
Record Nr. UNINA-9910715381503321
[Washington, D.C.] : , : [U.S. Government Publishing Office], , [2021]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
ANDA litigation : strategies and tactics for pharmaceutical patent litigators / / Kenneth L. Dorsney, editor-in-chief
ANDA litigation : strategies and tactics for pharmaceutical patent litigators / / Kenneth L. Dorsney, editor-in-chief
Pubbl/distr/stampa American Bar Association
Disciplina 346.7304/86
Soggetto topico Biotechnology - United States - Patents
Drugs - United States - Patents
Patent suits - United States
Pharmacy - Law and legislation - United States
Soggetto non controllato Abbreviated New Drug Application
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto The statutory and regulatory scheme -- The drug approval process--an overview -- Notice and prefiling considerations -- The litigation timeline -- Initiating litigation -- Use of reissue proceedings in Hatch-Waxman litigation -- Inter partes review in ANDA litigation -- Examining subject-matter jurisdiction over declaratory judgment claims filed in combination with patent infringement claims under section 271(e)(2)(a) -- Responding to the complaint -- Discovery -- Experts -- Claim construction -- Summary judgment -- Remedies -- Settlement -- Antitrust -- Pretrial preparation -- Trial -- Posttrial -- Appeals to the Court of Appeals for the Federal Circuit -- Hatch-Waxman practice in the Supreme Court of the United States -- Managing an ANDA litigation -- Pharmaceutical regulation and litigation in foreign countries.
Altri titoli varianti ANDA litigation
Record Nr. UNINA-9910671107803321
American Bar Association
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019
Pubbl/distr/stampa Washington : , : U.S. Government Publishing Office, , 2021
Descrizione fisica 1 online resource (vi, 246 pages)
Soggetto topico Prescription pricing - United States - Public opinion
Drugs - Generic substitution - Law and legislation - United States
Drugs - Law and legislation - United States
Drugs - United States - Patents
Patent laws and legislation - United States
Competition - United States
Pharmaceutical industry - United States
Soggetto genere / forma Legislative hearings.
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Lowering the cost of prescription drugs
Record Nr. UNINA-9910715471103321
Washington : , : U.S. Government Publishing Office, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Patent Fairness Act of 1999 : hearing before the Subcommittee on Courts and Intellectual Property of the Committee on the Judiciary, House of Representatives, One Hundred Sixth Congress, first session, on H.R. 1598, July 1, 1999
Patent Fairness Act of 1999 : hearing before the Subcommittee on Courts and Intellectual Property of the Committee on the Judiciary, House of Representatives, One Hundred Sixth Congress, first session, on H.R. 1598, July 1, 1999
Descrizione fisica 1 online resource (180 p.) : ill
Soggetto topico Patent laws and legislation - United States
Drugs - United States - Patents
Patent extensions - United States
Soggetto non controllato Air warfare
History
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Patent Fairness Act of 1999
Record Nr. UNINA-9910689317603321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pipeline drugs : proposed remedies for relief in the Drug Patent Term Restoration Review Procedure Act of 1999 : hearing before the Committee on the Judiciary, United States Senate, One Hundred Sixth Congress, first session, on S. 1172 ... August 4, 1999
Pipeline drugs : proposed remedies for relief in the Drug Patent Term Restoration Review Procedure Act of 1999 : hearing before the Committee on the Judiciary, United States Senate, One Hundred Sixth Congress, first session, on S. 1172 ... August 4, 1999
Descrizione fisica 1 online resource (iv, 124 p.) : ill
Soggetto topico Patent medicines - Law and legislation - United States
Patent extensions - United States
Drugs - United States - Patents
Soggetto non controllato United States
Patent medicines
Political science
Law
Medical
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Pipeline drugs
Record Nr. UNINA-9910689495303321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui